Difference in growth hormone response to growth hormone-releasing hormone (GHRH) testing following GHRH subacute treatment in normal aging and growth hormone-deficient adults: Possible perspectives for therapeutic use of GHRH or its analogs in elderly subjects?

References

• Corpas, E., Harman, S.M., Blackman, M.R. Human growth hormone and human aging. Endocr. Rev. 1993, 14, 20–39.
   PubMed Web of Science ®Google Scholar
• Ho, K.K., Hoffman, D.M. Aging and growth hormone. Horm. Res. 1993, 40, 80–86.
   PubMedGoogle Scholar
• Harman, S.M., Blackman, M.R. Use of growth hormone for prevention or treatment of effects of aging. J. Gerontol. A Biol. Sci. Med. Sci. 2004, 59, 652–658.
   PubMedGoogle Scholar
• Rudman, D., Kutner, M.H., Rogers, C.M., Lubin, M.F., Fleming, G.A., Bain, R.P. Impaired growth hormone secretion in the adult population: relation to age and adiposity. J. Clin. Invest. 1981, 67, 1361–1369.
   PubMed Web of Science ®Google Scholar
• Zadik, Z., Chalew, S.A., McCarter, R.J. Jr, Meistas, M., Kowarski, A.A. The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J. Clin. Endocrinol. Metab. 1985, 60, 513–516.
   PubMed Web of Science ®Google Scholar
• Prinz, P.N., Weitzman, E.D., Cunningham, G.R., Karacan, I. Plasma growth hormone during sleep in young and aged men. J. Gerontol. 1983, 38, 519–524.
   PubMedGoogle Scholar
• Muggeo, M., Fedele, D., Tiengo, A., Molinari, M., Crepaldi, G. Human growth hormone and cortisol response to insulin stimulation in aging. J. Gerontol. 1975, 30, 546–551.
   PubMedGoogle Scholar
• Monteleone, P., Iovino, M., Orio, F., Steardo, L. Impaired growth hormone response to sodium valproate in normal aging. Psychopharmacology (Berl.) 1987, 91, 10–13.
   PubMedGoogle Scholar
• Iovino, M., Monteleone, P., Steardo, L. Repetitive growth hormone-releasing hormone administration restores the attenuated growth hormone (GH) response to GH-releasing hormone testing in normal aging. J. Clin. Endocrinol. Metab. 1989, 69, 910–913.
   PubMedGoogle Scholar
• Giustina, A., Veldhuis, J.D. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr. Rev. 1998, 19, 717–797.
   PubMed Web of Science ®Google Scholar
• Ceda, G.P., Valenti, G., Butturini, U., Hoffman, A.R. Diminished pituitary responsiveness to growth hormone-releasing factor in aging male rats. Endocrinology 1986, 118, 2109–2114.
   PubMedGoogle Scholar
• Arvat, E., Giordano, R., Gianotti, L., Broglio, F., Camanni, F., Ghigo, E. Neuroendocrinology of the human growth hormone-insulin-like growth factor I axis during ageing. Growth Horm. IGF Res. 1999, 9 Suppl A, 111–115.
   PubMedGoogle Scholar
• Müller, E.E., Cella, S.G., Parenti, M., Deghenghi, R., Locatelli, V., De Gennaro Colonna, V., Torsello, A., Cocchi, D. Somatotropic dysregulation in old mammals. Horm. Res. 1995, 43, 39–45.
   PubMedGoogle Scholar
• Ghigo, E., Goffi, S., Nicolosi, M., Arvat, E., Valente, F., Mazza, E., Ghigo, M.C., Camanni, F. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. J. Clin. Endocrinol. Metab. 1990, 71, 1481–1485.
   PubMed Web of Science ®Google Scholar
• Veldhuis, J.D., Liem, A.Y., South, S., Weltman, A., Weltman, J., Clemmons, D.A., Abbott, R., Mulligan, T., Johnson, M.L., Pincus, S. Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J. Clin. Endocrinol. Metab. 1995, 80, 3209–3222.
   PubMed Web of Science ®Google Scholar
• Thissen, J.P., Ketelslegers, J.M., Underwood, L.E. Nutritional regulation of the insulin-like growth factors. Endocr. Rev. 1994, 15, 80–101.
   PubMed Web of Science ®Google Scholar
• Giagulli, V.A., Carbone, D. Hormonal control of inhibin B in men. J. Endocrinol. Invest. 2006, 29, 706–713.
   PubMed Web of Science ®Google Scholar
• Locatelli V, Arimura A, Torsello A, Cella SG, Muller EE. Somatostatin antiserum antagonizes the impaired ability of hpGRS-40 to stimulate GH-release in old unanesthesized male rats. Neuroendocrinol Lett 1984, 6, 261–266.
   Google Scholar
• Soule, S.G., Macfarlane, P., Levitt, N.S., Millar, R.P. Contribution of growth hormone-releasing hormone and somatostatin to decreased growth hormone secretion in elderly men. S. Afr. Med. J. 2001, 91, 254–260.
   PubMedGoogle Scholar
• Veldhuis, J.D., Patrie, J.T., Frick, K., Weltman, J.Y., Weltman, A. Sustained growth hormone (GH) and insulin-like growth factor I responses to prolonged high-dose twice-daily GH-releasing hormone stimulation in middle-aged and older men. J. Clin. Endocrinol. Metab. 2004, 89, 6325–6330.
   PubMedGoogle Scholar
• Zhan, X., Giorgianni, F., Desiderio, D.M. Proteomics analysis of growth hormone isoforms in the human pituitary. Proteomics 2005, 5, 1228–1241.
   PubMedGoogle Scholar
• Kanashiro-Takeuchi, R.M., Tziomalos, K., Takeuchi, L.M., Treuer, A.V., Lamirault, G., Dulce, R., Hurtado, M., Song, Y., Block, N.L., Rick, F., Klukovits, A., Hu, Q., Varga, J.L., Schally, A.V., Hare, J.M. Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction. Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 2604–2609.
   PubMedGoogle Scholar
• Lin-Su, K., Wajnrajch, M.P. Growth Hormone Releasing Hormone (GHRH) and the GHRH Receptor. Rev. Endocr. Metab. Disord. 2002, 3, 313–323.
   PubMedGoogle Scholar
• Kiaris, H., Schally, A.V., Kalofoutis, A. Extrapituitary effects of the growth hormone-releasing hormone. Vitam. Horm. 2005, 70, 1–24.
   PubMedGoogle Scholar
• Siriwardana, G., Bradford, A., Coy, D., Zeitler, P. Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase. Mol. Endocrinol. 2006, 20, 2010–2019.
   PubMedGoogle Scholar
• Schally, A.V., Varga, J.L., Engel, J.B. Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer. Nat. Clin. Pract. Endocrinol. Metab. 2008, 4, 33–43.
   Google Scholar
• Bellyei, S., Schally, A.V., Zarandi, M., Varga, J.L., Vidaurre, I., Pozsgai, E. GHRH antagonists reduce the invasive and metastatic potential of human cancer cell lines in vitro. Cancer Lett. 2010, 293, 31–40.
   PubMedGoogle Scholar
• Barabutis, N., Siejka, A., Schally, A.V. Effects of growth hormone-releasing hormone and its agonistic and antagonistic analogs in cancer and non-cancerous cell lines. Int. J. Oncol. 2010, 36, 1285–1289.
   PubMedGoogle Scholar
• Guo, J., Schally, A.V., Zarandi, M., Varga, J., Leung, P.C. Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway. Reprod. Biol. Endocrinol. 2010, 8, 54.
   Google Scholar
• Bartke, A. Is growth hormone deficiency a beneficial adaptation to aging? Evidence from experimental animals. Trends Endocrinol. Metab. 2003, 14, 340–344.
   PubMed Web of Science ®Google Scholar